Jeremy Burtenshaw
Advertisement
Articles by Jeremy Burtenshaw
Advertisement
Latest Updated Articles
- Can MTM Programs Decrease Adverse Drug Events?
Published: March 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
2
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
3
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
4
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
5
